Commentary On Flu And Pneumonia Vaccination And Reduced Risk Of Alzheimer’s Dementia

Vaccines have become one of the most discussed topics during the COVID-19 pandemic. From development to distribution, the whole world has their eyes on a new vaccine. However, promising new data has now brought common vaccines even to the forefront of discussion in the study of Alzheimer’s disease (AD). At the 2020 Alzheimer’s Association International Conference this week (#AAIC20), newly presented data shows how flu and pneumonia vaccines may lower the risk for Alzheimer’s disease (AD).

To read the full article, click Here.

Congrats To UCI MIND Researchers On Highly Accessed AD Vaccine Paper

The journal Alzheimer’s Research & Therapy, in celebrating the 10th Anniversary of the journal included a list of their 10 most accessed papers of the last year. A manuscript by UCI MIND researchers Hayk Davtyan, Morgan Coburn, David Cribbs, and Mathew Blurton-Jones made the list. Their article, “Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice” had been accessed by researchers more than 14,000 times! Congratulations to their team.

To read more, Dr. Davtyan spoke about the manuscript on page 7 of the Winter 2020 Newsletter.

Novel Chimeric Rodent Model Yields Vital Information about Alzheimer’s

Novel Chimeric Rodent Model Yields Vital Information about Alzheimer’s

Scientists at the University of California, Irvine, report that they used a chimeric model to learn how key human brain immune cells respond to Alzheimer’s. By developing a way for these microglia to grow and function in mice, the team says researchers now have an unprecedented view of crucial mechanisms contributing to the disease.

The scientists, led by Mathew Blurton-Jones, PhD, associate professor of neurobiology & behavior, believe their findings also hold promise for investigating many other neurological conditions such as Parkinson’s, traumatic brain injury, and stroke. Their study (“Development of a Chimeric Model to Study and Manipulate Human Microglia in vivo”) appears in Neuron.

Chimeric Model Alzheimer's graphical abstract

To read the full article, click Here.

Call it Mighty Mouse: Breakthrough leaps Alzheimer’s research hurdle

UCI-led study reveals crucial mechanisms contributing to the disease

University of California, Irvine researchers have made it possible to learn how key human brain cells respond to Alzheimer’s, vaulting a major obstacle in the quest to understand and one day vanquish it. By developing a way for human brain immune cells known as microglia to grow and function in mice, scientists now have an unprecedented view of crucial mechanisms contributing to the disease.

The team, led by Mathew Blurton-Jones, associate professor of neurobiology & behavior, said the breakthrough also holds promise for investigating many other neurological conditions such as Parkinson’s, traumatic brain injury, and stroke. The details of their study have just been published in the journal Neuron. Link to study: https://www.cell.com/neuron/fulltext/S0896-6273(19)30600-2.

To read the full article, click Here.

Dr. Blurton-Jones Awarded Grant To Identify Potential Treatments For Alzheimer’s Disease

By Kirsten

UCI MIND faculty member Dr. Mathew Blurton-Jones was awarded a $500,000 grant from Orange County Community Foundation to test 1200+ FDA-approved compounds for effectiveness in Alzheimer’s disease treatment. His lab seeks to find the top 20 genes and drugs that safely prevent brain damage caused by microglia, which are critical immune cells in the brain that ‘prune’ unnecessary neuronal connections, or synapses. In the brains of people with Alzheimer’s disease, damage can be caused by microglia ‘overpruning’ synapses, leading to loss of necessary connections. UCI News reports that Dr. Blurton-Jones and his team are “grateful to be the recipients of this OCCF grant and remain confident that through our clinical trials and studies, we could be well on our way toward finding a cure for Alzheimer’s disease.”

Click here to read more from UCI News

UC Irvine study delves into why women are more likely than men to suffer from Alzheimer’s

Two UC Irvine researchers recently began investigating why women are almost twice as likely as men to be diagnosed with Alzheimer’s disease.

Drs. Sunil Gandhi and Mathew Blurton-Jones were the winners of a $100,000 grant competition organized by UCI’s Institute for Memory Impairments and Neurological Disorders (UCI MIND) and the Women’s Alzheimer’s Movement, a group founded by Maria Shriver.

Dr. Josh Grill, co-director of UCI MIND, said the move is meant to help focus some of the institute’s best scientists on finding out what leads to the sex disparity in Alzheimer’s diagnoses.

“The idea with this recent partnership is to focus the energy of our best scientists on the relationship between Alzheimer’s and sex and gender,” Grill said. “This’ll let our scientists gather some preliminary data that will make them competitive for larger grants.”

Grill said researchers have traditionally traced the disparity to women’s longer lifespans, considering they are more likely to live to the ages where the risk for Alzheimer’s increases exponentially.

Grill said that while this is the biggest contributor to the imbalance, it’s not the entire explanation.

New research published in June suggested that hormonal influences or pregnancy-related changes in the immune system may increase women’s risk. …

To read the full article from Daily Pilot, click Here.